Xencor

-$0.22 (-0.98%) Today
$0.00 (0.00%) As of 8:01 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.

About XNCR

Xencor, Inc. is biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.

CEO
Bassil I. Dahiyat
Employees
254
Headquarters
Monrovia, California
Founded
1997

XNCR Key Statistics

Market cap
1.32B
Price-Earnings ratio
12.65
Dividend yield
—
Average volume
314.44K
High today
$23.07
Low today
$22.05
Open price
$22.42
Volume
222.45K
52 Week high
$43.61
52 Week low
$21.98

XNCR News

Simply Wall StMay 24

Shareholders in Xencor have lost 42%, as stock drops 3.7% this past week - Simply Wall St

It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory retu

XNCR Earnings

-$0.69
-$0.06
$0.58
$1.21
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure